TranspariMED clinical trial transparency

8 May 2017

New study documents how the lack of clinical trials transparency harms patients, taxpayers and investors, based on six in-depth case studies.

16 Mar 2017

Clinical trials’ integrity and utility is routinely undermined by flaws in design, methods, publication and interpretation, a paper published in Trials concludes.

While the paper does not present new data, its summary of salient factors and the corresponding literature makes it a valuable point of departure for researchers and campaigners in the field of evidence-based medicine.

...

17 Feb 2017

Pharma-sponsored drug and device trial studies are about 30% more likely to have results and conclusions that favour the sponsor, a new Cochrane Library review has found.

The review found that studies run by pharma companies routinely show greater efficacy and less harms. The authors outlined some common ways in which sponsors can influence study outcomes, including the framing...

Please reload

Subscribe
Recent Posts
Please reload

This site was designed with the
.com
website builder. Create your website today.
Start Now